Kuan-chung Hsiao

Title: Kuan-chung Hsiao: Innovator in Antibody Development

Introduction

Kuan-chung Hsiao is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific receptors involved in vascular processes.

Latest Patents

One of Hsiao's key patents is titled "Dual-function antibodies targeting VEGFR2 and VEGFR3." This patent describes an isolated antibody that comprises heavy chain complementary determining regions CDR1, CDR2, and CDR3 from a heavy chain variable region sequence having SEQ ID NO: 1 or 3. It also includes light chain complementary determining regions CDR1, CDR2, and CDR3 from a light chain variable region sequence having SEQ ID NO: 2 or 4. The antibody binds specifically to both vascular endothelial growth factor receptor-2 (VEGFR2) and vascular endothelial growth factor receptor-3 (VEGFR3). Hsiao holds 1 patent related to this innovative work.

Career Highlights

Kuan-chung Hsiao is affiliated with the National Health Research Institutes, where he continues to advance research in antibody development. His work has implications for therapeutic applications in various medical fields.

Collaborations

Hsiao has collaborated with notable colleagues, including Neng-Yao Shih and Ko-Jiunn Liu, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kuan-chung Hsiao's contributions to antibody research exemplify the impact of innovative thinking in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.